Summit Partners Public Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $5.3 Million - $6.28 Million	-20,722 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $23.5 Million - $30.8 Million	-104,236 Reduced 83.42%	20,722 $6.02 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $25 Million - $31 Million	124,958 New	124,958 $29.7 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $10.6 Million - $12.4 Million	-70,090 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $2.76 Million - $3.12 Million	20,090 Added 40.18%	70,090 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $7.41 Million - $8.11 Million	50,000	50,000 $7.6 Million

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

220M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$11.8 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.2 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.37 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.19 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.96 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account